SN Bioscience’s SNB-101 wins FDA orphan drug designation for gastric cancer
The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38
The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
The therapy also drove additional weight loss at the higher 1.8 mg dose without plateauing and maintained a favorable tolerability profile
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
Subscribe To Our Newsletter & Stay Updated